Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Insulin Therapy and Falls Due to Orthostatic Hypotension (Pilot Study)

Trial Profile

Insulin Therapy and Falls Due to Orthostatic Hypotension (Pilot Study)

Status: Withdrawn prior to enrolment
Phase of Trial: Phase IV

Latest Information Update: 12 Jan 2018

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Insulin glargine (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 08 Jan 2018 Planned End Date changed from 1 Jul 2019 to 2 Jan 2018.
    • 08 Jan 2018 Planned primary completion date changed from 1 Sep 2018 to 2 Jan 2018.
    • 08 Jan 2018 Status changed to withdrawn prior to enrolment.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top